Modelling the influence of changes in vaccination timing, timeliness and coverage on the example of measles outbreaks in the UK between 2010-19
Suffel, A. M.; Warren-Gash, C.; McDonald, H. I.; Kucharski, A. J.; Robert, A.
Show abstract
BackgroundThe Measles-Mumps-Rubella vaccine is given as a two-dose course in childhood, but the schedule of the second dose varies between countries. England recommended bringing forward the second dose from three years and four months to 18 months by 2025. We aim to quantify how changing the vaccine schedule could impact measles transmission dynamics. MethodsWe used a mathematical model stratified by age group and region to generate stochastic outbreaks with different vaccine schedules. We used detailed information on vaccine uptake for different age groups by region and year from electronic health records and modelled alternative scenarios changing the timing of the second MMR dose or changing uptake of either dose. We simulated measles incidence between 2010 and 2019 and compared the number of cases in each scenario. Results and discussionDelivering the second MMR vaccine at younger age resulted in a lower number of cases than in the reference set of simulations with 16% (IQR: 1.93- 28.48%) cases averted when the second dose was given at 18 months. The number of cases decreased even if the coverage of the second dose decreased by up to 3% (median reduction 15.94%; IQR: 0.41 -28.21%). The impact on case numbers was equivalent to increasing first dose coverage by 0.5% every year between 2010 and 2019 (16.38 % reduction, IQR:1.90 - 28.45), more cases could be avoided (28.60%, IQR: 17.08 - 38.05) if the first dose coverage was increased by 1% every year. Our data highlighted how patterns of vaccination uptake translate into outbreak risk. Although increasing coverage of the first MMR dose led to the best results, this may be challenging to achieve requiring substantial resources with already high coverage of the first dose. Hence, an earlier second MMR dose presents a good alternative for mitigating the risk of measles outbreaks.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Potential health and economic impact of paediatric vaccination using next generation influenza vaccines in Kenya: a modelling study 96%
- Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis 94%
- Projecting vaccine demand and impact for emerging zoonotic pathogens 94%
Similar papers in this journal
- Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada 95%
- Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022 94%
- Cost-effectiveness of routine COVID-19 adult vaccination programmes in England 94%
Similar papers in this journal
- The risk of future mpox outbreaks among men who have sex with men: a modelling study based on cross-sectional seroprevalence data 92%
- Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection in the Netherlands, September to December 2022 91%
- Recording of 'COVID-19 vaccine declined' among vaccination priority groups: a cohort study on 57.9 million NHS patients' primary care records in situ using OpenSAFELY 91%
Similar papers in this journal
- Health impact and cost-effectiveness of COVID-19 vaccination in Sindh Province, Pakistan 96%
- Long term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: a modelling study 94%
- Uptake of infant and pre-school immunisations in Scotland and England during the COVID-19 pandemic: an observational study of routinely collected data 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.